Literature DB >> 14624067

Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity.

Egemen Savaskan1, Gianfranco Olivieri, Fides Meier, Erich Seifritz, Anna Wirz-Justice, Franz Müller-Spahn.   

Abstract

BACKGROUND: beta-Amyloid peptide (Abeta), a neutrotoxic substance, has been implicated to a great degree in cell death during the course of AD. Resveratrol, a natural polyphenol mainly found in red wine, has been shown to be cardioprotective and chemoprotective. Since a moderate wine intake correlates with a lower risk for Alzheimer disease (AD), an additional neuroprotective effect has been postulated for resveratrol.
OBJECTIVE: The present study aimed at elucidating the possible neuroprotective effects of resveratrol against Abeta-induced neurotoxicity.
METHODS: The neuroprotective capacity against Abeta-related oxidative stress was studied in a cell culture model suitable for studying such potentially neuroprotective substances.
RESULTS: Resveratrol maintains cell viability and exerts an anti-oxidative action by enhancing the intracellular free-radical scavenger glutathione.
CONCLUSION: Our findings suggest that red wine may be neuroprotective through the actions of resveratrol. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624067     DOI: 10.1159/000073766

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  36 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  The impact of nutrition on cognition in the elderly.

Authors:  Kathleen Van Dyk; Mary Sano
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

3.  Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain.

Authors:  Mostafa Rahvar; Mohsen Nikseresht; Sayed Mohammad Shafiee; Fakhraddin Naghibalhossaini; Mozhgan Rasti; Mohammad Reza Panjehshahin; Ali Akbar Owji
Journal:  Neurochem Res       Date:  2011-01-09       Impact factor: 3.996

Review 4.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

Review 5.  Caloric restriction: beneficial effects on brain aging and Alzheimer's disease.

Authors:  Caroline Van Cauwenberghe; Charysse Vandendriessche; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mamm Genome       Date:  2016-05-30       Impact factor: 2.957

Review 6.  Redox-based therapeutics in neurodegenerative disease.

Authors:  G J McBean; M G López; F K Wallner
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

7.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

8.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

9.  Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells.

Authors:  Hongqiao Zhang; Albert Shih; Alessandra Rinna; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2008-10-22       Impact factor: 4.013

10.  Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.

Authors:  Tiffany F Hughes; Mary Ganguli
Journal:  Curr Psychiatry Rev       Date:  2009-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.